Hispanics don’t develop skin cancer at the same rate Caucasians do. But that doesn't mean Hispanics are immune from skin cancer. Practicing skin cancer prevention is important for everyone, regardless of culture or spoken language.

While the incidence of prostate cancer is greater in older men, the screening guidelines are murky. A new study analyzed what happened after older men were screened. 

The statistics are pretty clear that most American men are not going to die of prostate cancer. But the question remains: who should be screened and how often? A new crystal ball may be on the horizon.

Some women know they’re at high risk of developing breast cancer. The disease could run in the family or they may have a number of other risk factors. So, do medications reduce breast cancers in these women?

Suspicious looking areas on a mammogram are hard to interpret. That’s why computer technology is used as a second pair of eyes. This technology has definite benefits, according to a new study, along with some potential disadvantages.

Radiation therapy has helped many patients fight cancer. However, the treatment often takes a toll on the heart and affects survival rates for those who have heart surgery.

Asbestos is a known cancer-causing agent. It was banned in the United States in the 1970s, but can still be found in old insulation and other building materials. People who have been exposed to asbestos are at higher risk of respiratory diseases, including lung cancer.

The majority of breast cancers are fed by the hormones estrogen and progesterone. That’s why women with hormone-sensitive breast cancer are prescribed medicines to block these hormones. But a good portion of women may be skipping the therapy.

Cancer that either starts in or spreads to the bone can be extremely painful. So can cancers that begin in the muscles or other soft tissue of the body. A relatively new treatment method may bring much needed relief.

The US Preventive Services Task Force (USPSTF) has recently tackled the issues of when to screen for prostate and breast cancers. The government-backed agency is now saying there's not enough evidence to recommend or reject oral cancer screening.